Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates

Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.62 per share a year ago.

Zacks Investment Research • an hour ago

ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?

PDEX heads into fiscal Q1 earnings with strong medical-device sales and margin momentum, but customer concentration, a shrinking backlog and acquisition risks loom.

Zacks Investment Research • Oct 28, 2026

5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve

Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.

Zacks Investment Research • Oct 1, 2026

SRK Capital 2026 Semi-Annual Portfolio Update

SRK Fund I, LP increased 26.80% during the first half of the year. In contrast, the S&P 500 and the Russell 2000 returned 10.18% and 22.57%, respectively. ImmuCell delivered a strong first quarter in 2026, underscoring the earnings power and cash-flow potential of its core First Defense franchise after the company's strategic exit from Re-Tain. Since divesting its capital-intensive ammunition manufacturing business in April 2025, Outdoor Holding Company has operated as a pure-play, asset-light marketplace through GunBroker.com.

Seeking Alpha • Sep 21, 2026

New Strong Buy Stocks for September 18th

PGY, OPHC, PDEX, TRV and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 18th, 2026.

Zacks Investment Research • Sep 18, 2026

Best Momentum Stocks to Buy for September 18th

PDEX, APH and RELY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18th, 2026.

Zacks Investment Research • Sep 18, 2026

Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results

IRVINE, CA / ACCESS Newswire / September 3, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026.

Accesswire • Sep 3, 2026

Pro-Dex: Still A Buy, But Don't Chase

Pro-Dex reported nice Q1 sales of $19.9 million, which is up 14.6% YoY. Their largest customer contract now runs through December 2028, reducing potential near-term risks in that sense. Also, their APM acquisition gives them more control over their supply chain and brings some potential aerospace/defense optionality.

Seeking Alpha • May 15, 2026

Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results

IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 third quarter ended March 31, 2026.

Accesswire • Apr 30, 2026

Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining

IRVINE, CA / ACCESS Newswire / February 12, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition of Advanced Precision Machining LLC, ("APM"), formerly operated as Advanced Precision Machining, Inc., a manufacturing facility located in Costa Mesa, Calif.

Accesswire • Feb 12, 2026